69448-009-63 : NDC 2026 Code

69448-009-63 : Filgrastim-laha ( Filkri )

Additionally :

You can get information about “69448-009-63” NDC code in 69448-009-63 in HTML format

HTML | 69448-009-63 in TXT (Plain Text) format

TXT | 69448-009-63 in PDF (Portable Document Format)

PDF | 69448-009-63 in XML format

XML formats.

NDC Code : 69448-009-63 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69448-009-63",
    "PackageDescription": "1 SYRINGE in 1 BOX (69448-009-63)  / .8 mL in 1 SYRINGE",
    "NDC11Code": "69448-0009-63",
    "ProductNDC": "69448-009",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Filkri",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Filgrastim-laha",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS; SUBCUTANEOUS",
    "StartMarketingDate": "20260715",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761027",
    "LabelerName": "Accord BioPharma Inc.,",
    "SubstanceName": "FILGRASTIM",
    "StrengthNumber": "480",
    "StrengthUnit": "ug/.8mL",
    "Pharm_Classes": "Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-07-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260715",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}